Eton Pharmaceuticals's market cap is currently $491.83M. The company's EPS TTM is $-0.1; its P/E ratio is ―; Eton Pharmaceuticals is scheduled to report earnings on August 7, 2025, and the estimated EPS forecast is $0.09. See an overview of income statement, balance sheet, and cash flow financials.
